ESR1 and cancer: Niknafs et al. further confirmed that DSCAM-AS1 expression is induced by estrogen upon ER binding to the DSCAM-AS1 promoter and showed how the interaction between DSCAM-AS1 and hnRNPL leads to the more aggressive cancer phenotype.